|
PURA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.74110000042916E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.174110E-02 |
| Normal-vs-Stage2 |
1.532000E-01 |
| Normal-vs-Stage3 |
8.96230001323772E-09 |
| Normal-vs-Stage4 |
1.48459022852876E-12 |
| Stage1-vs-Stage2 |
7.900600E-01 |
| Stage1-vs-Stage3 |
3.976600E-04 |
| Stage1-vs-Stage4 |
8.74729999544854E-08 |
| Stage2-vs-Stage3 |
8.769900E-02 |
| Stage2-vs-Stage4 |
8.656900E-03 |
| Stage3-vs-Stage4 |
1.289190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12659999995657E-06 |
| Normal-vs-AfricanAmerican |
8.92840001931461E-09 |
| Normal-vs-Asian |
4.581000E-01 |
| Caucasian-vs-AfricanAmerican |
2.161000E-03 |
| Caucasian-vs-Asian |
7.647600E-01 |
| AfricanAmerican-vs-Asian |
1.182600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25430002337635E-09 |
| Normal-vs-Female |
5.195500E-03 |
| Male-vs-Female |
3.347900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.560240E-04 |
| Normal-vs-Age(41-60Yrs) |
5.994800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.54600000473937E-08 |
| Normal-vs-Age(81-100Yrs) |
2.671400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.495600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.554400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.913570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.214190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.078000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.097400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.056200E-01 |
| Normal-vs-Grade 2 |
4.086300E-02 |
| Normal-vs-Grade 3 |
1.75299999960465E-07 |
| Normal-vs-Grade 4 |
1.62625468647093E-12 |
| Grade 1-vs-Grade 2 |
3.886800E-01 |
| Grade 1-vs-Grade 3 |
4.291600E-02 |
| Grade 1-vs-Grade 4 |
3.97300000000156E-05 |
| Grade 2-vs-Grade 3 |
6.259400E-03 |
| Grade 2-vs-Grade 4 |
2.30189978189799E-10 |
| Grade 3-vs-Grade 4 |
1.95239999999375E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.301240E-01 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05369999999316E-05 |
| Normal-vs-N1 |
1.93330018660731E-10 |
| N0-vs-N1 |
1.184160E-03 |
|
|
